Table S2 from First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)